Skip to content

Cullinan Therapeutics, Inc. CGEM Geographic — Operating Lease Rentable Area

Similar metrics at other companies

Nuvation Bio logo
NUVBMA — Area Of Real Estate Property
$2.24K0.0%
KLR
KLRAMA — Area Of Office Space
39.5K
Lightwave Logic, Inc. logo
LWLGLease Area
9.7K
Nuvation Bio logo
NUVBMA — Lessee Operating Lease Expiration Year
2K0.0%
CubeSmart logo
CUBEMA — Area Of Real Estate Property
$1.25M-0.3%
Nurix Therapeutics, Inc. logo
NRIXArea of office space leased
57.9K

Other financials

Income statement

See full
Revenue-
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%
EPS (diluted)-$0.69+24.2%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total equity$408.7M-30.8%
Total assets$403.0M-30.5%

Cash flow

See full
Operating cash flow-$46.0M-6.7%
CapEx$11.0K
Free cash flow-$38.1M-4.1%

Valuation

See full
Market cap$1.08B+151%
Enterprise value$1.01B+181%

Profitability

See full
Operating margin-358.7%
Net margin-346.1%

Returns & leverage

See full
Return on equity-44%+26.2pp
Debt / equity0.0×
Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept cgem:OperatingLeaseRentableArea.

The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s geographic — operating lease rentable area.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s geographic — operating lease rentable area?
Cullinan Therapeutics, Inc. (CGEM) reported geographic — operating lease rentable area of 14K in Q1 2026.
How has Cullinan Therapeutics, Inc.'s geographic — operating lease rentable area changed year-over-year?
Cullinan Therapeutics, Inc.'s geographic — operating lease rentable area decreased by 99.6% year-over-year, from 3.5M to 14K.
What does geographic — operating lease rentable area mean?
This metric represents the total square footage or physical capacity available for use under operating lease agreements within a specific business segment or geographic region. It serves as a proxy for the company's physical footprint and infrastructure investment required to support clinical development and operational activities. Monitoring this figure helps investors assess the scale of facility expansion and the associated fixed cost commitments relative to the company's research and development pipeline.